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(he American Society of Nuclear Cardiology (ASNC) now
onsists of more than 4,700 nuclear cardiology profession-
ls. The 10th Annual Scientific Session (chaired by Dr.
iwakar Jain) was held from September 29 through Octo-
er 2, 2005 in Seattle Washington, with more than 1,500
egistrants in attendance. This four-day meeting was di-
ided into five major tracks (plenary sessions, core curricu-
um, advanced track, investigative track, and technical
rack), as well as read-with-the-expert sessions and satellite
ymposia. In addition, original research was contributed in
he form of abstract presentations, and included a compe-
ition for the Young Investigator Award.
LENARY SESSIONS
linical debates: controversies in clinical cardiology and
ardiac imaging. The first plenary session consisted of a
eries of debates, and the first considered the issue of screening
ll asymptomatic diabetic patients for coronary artery dis-
ase (CAD).
Dr. Frans J. Th. Wackers argued that screening was
ppropriate because of the well-documented excessive car-
iovascular morbidity and mortality in patients with diabe-
es. However, because the overall prevalence of silent CAD
s relatively low (22% in the Detection of Ischemia in
symptomatic Diabetes [DIAD] study), it is important to
dentify “enriched subgroups” with a higher diagnostic yield.
oronary artery calcium (CAC) scoring with electron beam
omputed tomography may be an appropriate and simple
rst step, and only patients with substantial CAC would
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ork; ††Yale University School of Medicine, New Haven, Connecticut; and the
‡Tufts-New England Medical Center, Boston, Massachusetts.t
Manuscript received November 11, 2005; revised manuscript received November
1, 2005, accepted November 29, 2005.equire stress radionuclide myocardial perfusion imaging
MPI). Dr. Raymond Gibbons argued that there is insuffi-
ient evidence that screening of asymptomatic diabetic
atients alters outcome. Moreover, the cost in health care
ollars to society would be staggering and prohibitive. He
rgued that primary prevention and treatment, and appro-
riate evidence-based testing would be more effective than
outine screening.
In the second debate, Drs. Jack Ziffer and Marcelo
iCarli addressed the pros and cons of non-invasive com-
uted tomography angiography (CTA). Dr. Ziffer believed
hat 64-slice computed tomography (CT) would ultimately
eplace stress MPI because of the detailed anatomic infor-
ation that can be obtained. Computed tomography not
nly detects CAC, coronary anatomy, and luminal stenoses
ut also visualizes alterations of the coronary vessel wall,
llowing plaque characterization. In addition, left ventricu-
ar (LV) function can readily be assessed by CT, making it
“one-stop stop.” The high specificity of CTA will allow
dequate exclusion of CAD with eventual replacement of
nvasive cardiac catheterization. Dr. DiCarli argued that
TA would not replace MPI because of inherent technical
imitations. Computed tomography angiography still has
imited spatial resolution for distal vessels; the overall
ensitivity for the presence of proximal stenoses is 95%, but
ecreases to 82% when distal stenoses are included. Multi-
lice CT is limited by the patient’s radiation exposure,
rrhythmias during acquisition, and nephrotoxicity of con-
rast. Also, coronary calcifications, frequently present in
lderly and diabetic patients, negatively affect diagnostic
ccuracy. Most important, extensive literature has shown
hat not coronary anatomy (CTA) but the ischemic burden
MPI) determines prognosis: coronary anatomy versus cor-
nary pathophysiology.
In the third debate, Drs. Timothy Bateman and Manuel
erquiera debated whether positron emission tomography
PET) MPI would replace single-photon emission computed
omography (SPECT) MPI. Dr. Bateman argued that PET
w
h
u
d
e
S
b
(
q
n
e
i
c
r
8
M
e
T
c
p
M
T
A
i
i
A
c
W
a
c
a
w
l
a
m
a
f
p
t
n
C
m
i
w
a
a
h
g
a
t
s
s
C
fi
i
m
t
c
i
m
n
f
t
C
I
N
c
i
n
(
t
r
p
p
t
u
t
c
t
p
v
m
a
l
p
i
t
i
s
r
f
1479JACC Vol. 47, No. 7, 2006 Bax et al.
April 4, 2006:1478–84 Meeting Highlights ASNC 2005as simply better because of higher spatial resolution,
igher contrast, higher count density, routine use of atten-
ation correction, and less scatter. Also, patient radiation
osimetry is considerably lower using short-lived positron
mitters, and PET imaging is substantially faster than
PECT imaging. The diagnostic yield of PET imaging has
een consistently better with PET than with SPECT
accuracy 87% vs. 71%). Dr. Cerquiera conceded that the
uality of PET was superior to that of SPECT, but he did
ot expect SPECT to be replaced by PET for practical and
conomic reasons. Positron emission tomography imaging
s difficult to perform in a regular clinical practice. The PET
amera and cyclotron are expensive, costly to operate,
equire large spaces and specially trained personnel. Lastly,
2Rubidium generators make it possible to perform PET
PI studies in facilities without a cyclotron but are still
xpensive.
he Mario Verani Memorial Lecture: Dr. Daniel Berman:
ardiac imaging in CAD: changing roles and changing
layers. The highlight of the second plenary session was the
ario Verani Memorial Lecture by Dr. Daniel Berman.
he Mario Verani lecture is presented each year at the
SNC annual meeting by a prominent nuclear cardiologist,
n memory of Dr. Mario Verani (1943 to 2001), a pioneer
n nuclear cardiology and founder and past president of the
SNC. Dr. Berman discussed the changes occurring in
ardiology, changing concepts, changing clinical questions.
ith the aging population, increase of obesity, diabetes,
nd metabolic syndrome, the clinical picture of CAD has
hanged. In addition, marked changes have occurred in the
bility to treat patients and reduce the risk. In the past, it
as sufficient to identify the patient who needed revascu-
arization; in the present era the challenge is to identify the
symptomatic patient who needs aggressive medical treat-
ent. The armamentarium of cardiac imaging has expanded
nd changed. Non-invasive cardiac imaging of anatomy and
unction is central to the diagnosis and management of
atients with known or suspected CAD. The new players in
he diagnostic game are, in addition to conventional radio-
uclide MPI with electrocardiogram (ECG)-gated SPECT,
Abbreviations and Acronyms
ASNC  American Society of Nuclear Cardiology
CAC  coronary artery calcium
CAD  coronary artery disease
CT  computed tomography
CTA  computed tomography angiography
ECG  electrocardiogram
ICD  implantable cardioverter-defibrillator
LV  left ventricular
MIBG  123I-metaiodobenzylguanidine
MPI  myocardial perfusion imaging
MRI  magnetic resonance imaging
PET  positron emission tomography
SPECT  single-photon emission computed tomographyT techniques, sophisticated echocardiographic techniques, aagnetic resonance imaging (MRI), and PET. Radionuclide
maging is increasingly combined with CT imaging. The
ealth of information provided by hybrid imaging devices
llows for the development of new diagnostic and management
lgorithms. Depending on the a priori risk of CAD, physicians
ave to decide if imaging is needed, and if so, which test.
Patients at low (15% likelihood of CAD) risk are
enerally not tested. Patients with typical and limiting
ngina must be sent directly to cardiac catheterization. In
he intermediate-risk populations (15% to 85% likelihood),
creening for CAC by CT scanning appears appropriate and
ubsequent management can be guided by the degree of
AC detected. Patients with CAC and extensive (quanti-
ed) myocardial ischemia on MPI should be managed
nvasively. On the other hand, patients with CAC but
inimal ischemia are candidates for aggressive medical
herapy. Computed tomography angiography may be indi-
ated in patients with CAC and moderate myocardial
schemia on MPI to ensure that no high-risk CAD is
issed. It seems likely that combined (or sequential) diag-
ostic testing with CT and SPECT (or PET) in the near
uture will provide means to diagnose CAD tailored to the
ype of patients and symptoms.
ORE CURRICULUM: ADVANCES
N CLINICAL NUCLEAR CARDIOLOGY
ew tracers in nuclear cardiology. Dr. James Udelson dis-
ussed the use of new tracers to assess cardiac sympathetic
nnervation and fatty acid metabolism. Cardiac sympathetic in-
ervation can be evaluated using 123I-metaiodobenzylguanidine
MIBG); tracer uptake in the heart is compared with activity in
he mediastinum, yielding the heart-to-mediastinum ratio. A
educed heart-to-mediastinum ratio is a powerful predictor of
oor outcome in patients with severe heart failure, even more
redictive than LV ejection fraction, peak oxygen consump-
ion, and pulmonary capillary wedge pressure.
More recent studies have compared perfusion with MIBG
ptake in patients with previous infarction and demonstrated
hat the extent of denervated myocardium frequently ex-
eeds the area of reduced perfusion. The clinical relevance of
his observation relates to the fact that patients with this
erfusion-MIBG mismatch could be at increased risk of
entricular arrhythmias, and it is hoped that MIBG imaging
ay help in the selection of patients who need an implant-
ble cardioverter-defibrillator (ICD). Improved patient se-
ection is needed, because the devices are costly and many
atients are potential candidates for ICD therapy. Accord-
ng to the Multicenter Automatic Defibrillator Implanta-
ion Trial (MADIT)-II criteria, patients with previous
nfarction and depressed LV ejection fraction (30%)
hould receive an ICD, but only 35% of these patients
eceived appropriate shocks over a three-year period.
Evaluation of free fatty acid metabolism can be per-
ormed with 123I-betamethyl-p-iodophenyl-pentadecanoic
cid. The main interest is identification of regions that
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Meeting Highlights ASNC 2005 April 4, 2006:1478–84ave recently been exposed to ischemia (“ischemic mem-
ry imaging”). After an ischemic attack, cardiac glucose
etabolism becomes increased, whereas free fatty acid
etabolism is depressed (shift towards anaerobic glycolysis).
n the hours after the ischemic attack, perfusion has normal-
zed frequently, but free fatty acid metabolism remains de-
ressed, and glucose utilization increased. The value of
8F-fluorodeoxyglucose for assessing increased glucose
tilization as a memory marker of ischemia was recently
emonstrated. Likewise, the value of betamethyl-p-
odophenyl-pentadecanoic acid for this purpose is cur-
ently under investigation.
ew pharmacologic stress agents. Dr. Robert Hendel
ddressed the new pharmacologic stress agents. This is an
mportant area of development, because each year approxi-
ately three million pharmacologic stress procedures are
erformed and, although serious adverse events are rare
e.g., atrioventricular block in 8% and bronchospasm in
1%), minor side effects are noted in 55% to 80% of
atients. Another challenge is that the currently available
harmacologic stress agents require a continuous infusion,
hereas bolus administration may be preferred for efficiency
n the stress laboratory. Under development are specific
2A adenosine agonists that will provide for a more specific
ardiac response. For these new agents, coronary hyperemia
s similar to adenosine, resulting in a three- to five-fold
ncrease in blood flow. However, in contrast to adenosine,
here is a marked increase in coronary blood flow but little
esponse in the peripheral circulation. Accordingly, the drop
n blood pressure is modest. The onset of action for these
ew agents is in the range of 1 to 3 min, and the duration
f action is 10 to 20 min. Current adenosine A2A
gonists under development with clinical trial evidence
nclude: Binodenoson (MRE-0470), Regadenoson (CVT-
146), and BMS 068645 (ATL-146e). Each of these new
roducts has no significant effects on atrioventricular con-
uction, and there appears to be a reduction in overall side
ffects as a result of damped peripheral vasodilation. More-
ver, the diagnostic information with these new A2A
denosine agonists is equivalent to that of adenosine,
lthough additional clinical trials and Food and Drug
dministration approval are still required for establishing
hese new pharmacologic stress agents as a valuable replace-
ent for adenosine or dipyridamole.
ECHNICAL TRACK: INNOVATIONS
N CLINICAL NUCLEAR CARDIOLOGY
ttenuation correction. Several presentations emphasized
he need to implement acquisition protocols that shorten
he total imaging time to increase patient throughput and
omfort. An extremely rapid protocol with 82Rb-ECG-
ated rest/stress PET/CT using Regadenoson (CVT-3146)
ould be completed in 15 min. In this protocol, the CT
ould be performed first allowing for attenuation correc- iion, followed by the rest-stress perfusion study with
2Rb-PET.
Furthermore, the importance of proper quality control for
ttenuation correction was heavily emphasized in order to
enerate high-quality diagnostic studies. Special emphasis was
laced on new technology, such as the newer small foot-print,
maller field-of-view, and cardiac dedicated SPECT sys-
ems. These systems, which use a moving radioactive line
ource for the transmission scan, are prone to body trunca-
ion artifacts that misrepresent the amount of attenuation
otentially affecting the emission projections. Transmission
mages should be visually or automatically analyzed to detect
hese truncations, and algorithms to compensate for these
runcations were also described.
Quality control for attenuation correction with hybrid
ET/CT and presumably SPECT/CT systems is also
mportant. Because the CT transmission scan is performed
xtremely fast as compared with the slower PET or SPECT
cquisition, there is a high probability for misregistration
etween the emission and transmission scans due to breath-
ng and cardiac motion. The importance of using manual or
utomatic algorithms to detect the transmission-emission
isregistration and subsequently correctly re-register both
cans was well documented.
DVANCED TRACK:
ULTI-MODALITY CARDIAC IMAGING
he evolving role of multi-modality cardiac imaging in the
linical management of CAD was the main focus of several
essions in the advanced track. The first session was a joint
ession with the American Society of Echocardiography,
hich was dedicated to assessment of function and perfu-
ion.
unction and perfusion: nuclear imaging versus echocar-
iography: joint session with the American Society of
chocardiography. Dr. Mario Garcia summarized the pa-
ameters of LV function that can be assessed by echocardi-
graphy, including LV ejection fraction, strain, diastolic
elaxation and electromechanical (dys)synchrony. Accurate
ssessment of these parameters requires the use of several
odern echocardiographic techniques, including contrast
chocardiography, three-dimensional echocardiography,
nd tissue Doppler imaging. Assessment of these variables
as important implications in the evaluation and treatment
f systolic and diastolic heart failure. The review of radio-
uclide methods of functional assessment by Dr. Gordon
ePuey focused on gated blood pool imaging using either
lanar methods or the more recently developed gated blood
ool SPECT method. The benefits of gated blood pool
PECT over the planar methods include the assessment of
oth right ventricular and LV function without the need for
erforming first-pass studies and improved evaluation of
egional wall motion. Dr. Sanjiv Kaul reviewed his extensive
ork on contrast echocardiography to demonstrate that
maging of perfusion defects, either with contrast echocar-
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s dependent on changes in blood volume in the microcircu-
ation that occur with upstream stenoses in the coronary
rteries. Dr. Douglas Miller emphasized the unique ability
f PET to provide quantitative measurements of absolute
lood flow, which can provide clinically important informa-
ion when balanced ischemia may be present and perfusion
efects may be minimal on SPECT perfusion images.
The remainder of the advanced track was dedicated to
ulti-modality imaging in two different clinical settings: the
etection of CAD and evaluation of heart failure.
etection of CAD. In the detection of CAD, both CT
echniques and scintigraphic perfusion imaging are impor-
ant. Traditionally, perfusion imaging with PET and
PECT was performed to assess ischemia as a marker for
bstructive CAD. With the introduction of CT techniques,
arlier identification of CAD is possible, in particular the
ssessment of atherosclerosis and CAC with electron beam
T and more recently non-invasive angiography with
ulti-slice CT. It thus appears that these techniques visu-
lize both ends of the spectrum of CAD, and it is logical
hat the information should be integrated to further opti-
ize evaluation of CAD. Dr. Paolo Raggi reviewed the role
f assessing CAC and CTA, whereas Dr. Marcelo DiCarli
rovided important data demonstrating the integrated use
f ischemia detection by PET perfusion imaging with
ssessment of coronary anatomy by multi-slice CT. Indeed,
ith integration of information on atherosclerosis and
schemia, it will be possible to better define high-risk and
ow-risk groups of patients with CAD.
valuation of heart failure. Dr. Frank Bengel highlighted
he roles of SPECT or PET and MRI in the evaluation of
eart failure. Whereas MRI will provide important anatom-
cal information on the shape, dimension, and function of
he LV and right ventricle, information on blood flow,
etabolism, and innervation can be provided by SPECT or
ET and integration of the two imaging modalities will
mprove understanding and evaluation of patients with heart
ailure. Assessment of underlying etiology will be feasible,
nd subsequent implications for therapy can be derived. For
xample, Drs. Avjit Lahiri and Vasken Dilsizian illustrated
hat combined assessment of perfusion and metabolism by
uclear techniques and assessment of LV function by MRI
or echocardiography) helps to identify patients with isch-
mic cardiomyopathy who may benefit from revasculariza-
ion. In addition, nuclear imaging with PET or SPECT
ay also allow prediction of response to certain medical
herapies, for example the response to beta-blockers. Dr.
eroen Bax discussed the challenge of identifying patients
ho will benefit from cardiac resynchronization therapy.
ost likely, patients with LV dyssynchrony will benefit
ost from cardiac resynchronization therapy. Although
here are studies that suggest phase image analysis of gated
lood pool studies may provide information on LV dyssyn-
hrony, most of the studies thus far have used echocardi-
graphy (in particular tissue Doppler imaging) for the retection of LV dyssynchrony and subsequent prediction of
esponse to cardiac resynchronization therapy.
NVESTIGATIVE TRACK:
DVANCES IN CARDIAC IMAGING
tem cell therapy. Cell transplant strategies for myocardial
epair and regeneration represent a new frontier in the
reatment of cardiovascular disease. As summarized by Dr.
harles Murry, numerous hurdles must be overcome before
he potential of these strategies can be realized. For exam-
le, which cell type will be the most successful in improving
yocardial function? If there is improvement in function,
hat is the mechanism responsible for this beneficial effect?
ne of the most notable challenges is accurate non-invasive
maging for the characterization of cell delivery, survival,
igration, proliferation, and persistence. Dr. Dara Kraitch-
an discussed the role of MRI and SPECT/CT in this
egard. For example, the superparamagnetic iron oxide
article labeling of mesenchymal stem cells permits the
etection of migration and persistence of these cells when
njected into the site of myocardial infarction. However, a
ajor limitation of the method is the loss of signal that
ccurs using these iron particles, making anatomical MRI
valuation difficult and limiting the differentiation of labeled
esenchymal stem cells from artifacts. One potential ap-
roach to overcome this limitation is to develop an MRI
cquisition scheme that creates positive contrast with these
articles. SPECT/CT imaging of ex vivo labeled mesen-
hymal stem cells with 111Indium-oxine is also capable of
ssessing cell trafficking. The advantage of using 111Indium
s that it is commercially available and its long physical
alf-life (67 h) permits serial imaging for up to approxi-
ately one week post-injection. Although lung uptake
onfounds the initial image analysis, myocardial homing of
esenchymal stem cells can be detected within an infarct
one of dog hearts approximately 24 to 48 h after injection
r even 96 h after infarction. Of note, labeling with
11Indium-oxine did not appear to impair the functionality
f the mesenchymal stem cells, suggesting a potential
linical role for this approach. Dr. Joseph Wu highlighted
he role of reporter genes and reporter probes in the
ssessment of stem cell migration, proliferation, and sur-
ival. In this method, cells are transfected with reporter
enes, before myocardial implantation. Reporter gene ex-
ression will only occur if the cells are alive. Reporter probes
an be labeled with MRI, optical or radionuclide contrast
gents. Radiolabeling of reporter probes with 18F permits
ne to take advantage of the high sensitivity, quantitative
nd three-dimensional imaging capabilities of PET. One
uch example is the tracking of embryonic cardiomyoblasts
xpressing the mutant derivative of herpes simplex virus
ype 1 thymidine kinase with the reporter probe 18F-9-(4-
uoro-3-hydroxymethylbutyl) guanine in rat myocardium
sing small animal PET. One of the unique aspects of the
eporter gene method is the availability of numerous types of
r
i
C
t
a
a
d
m
s
d
b
l
p
o
fl
d
r
d
o
u
m
b
t
h
f
a
t
m
S
t
o
H
c
c
O
A
c
a
J
s
Y
A
a
f
T
c
t
c
p
w
u
i
t
a
t
a
c
s
w
e
E
a
s
i
e
t
w
b
s
a
s
i
w
o
i
c
r
C
s
a
e
a
a
t
p
m
r
q
t
r
e
c
a
s
a
S
p
n
a
s
u
p
v
M
p
a
1482 Bax et al. JACC Vol. 47, No. 7, 2006
Meeting Highlights ASNC 2005 April 4, 2006:1478–84eporter genes that should facilitate the labeling and track-
ng of different cell types.
ardiac metabolism. There is a growing body of evidence
hat alterations in myocardial substrate use play a key role in
variety of normal and abnormal cardiac conditions such as
ging, LV hypertrophy, and diabetic heart disease. As
iscussed by Dr. Raymond Russell, one of the key aspects of
yocardial health is its ability to switch to different energy
ubstrates in response to stimuli such as changes in substrate
elivery, the level of cardiac work, or a decline in myocardial
lood flow. In a variety of diseases this flexibility is lost,
eading to an overdependence on glucose (such as in
ressure-load LV hypertrophy and dilated cardiomyopathy)
r fatty acids (as occurs in obesity and diabetes). The loss of
exibility in myocardial substrate use can have numerous
etrimental effects including energy deprivation, oxygen free
adical formation, and lipotoxicity. Dr. Robert Gropler
iscussed how PET using appropriate mathematical models
f the myocardial kinetics of novel radiotracers could be
sed to quantify various aspects of myocardial substrate
etabolism. Positron emission tomography methods have
een used to verify that the same metabolic perturbations
hat are present in small animal models of disease have
uman correlates, thus providing an imaging platform to
acilitate the bi-directional translation between the bench
nd the bedside. Moreover, these PET methods can be used
o evaluate the efficacy of therapies designed to favorably
anipulate myocardial substrate metabolism. Dr. Heinrich
chelbert summarized the most common current applica-
ions of myocardial metabolic imaging, the characterization
f myocardial substrate use in ischemic heart disease.
ighlighted were both the research contributions and the
urrent role of PET with 18F-fluorodeoxyglucose in patient
are.
RIGINAL RESEARCH
total of 83 abstracts were selected from a group of
ompetitive submissions after peer review. All selected
bstracts were published in the July/August issue of the
ournal of Nuclear Cardiology. The following is a brief
ynopsis highlighting some of the work presented.
oung Investigator Award. In the Young Investigator
ward, seven best abstracts were selected, and the winning
bstract was presented by Dr. Sujoya Dey and colleagues
rom the University of Michigan (see the following text).
hree abstracts concerned technical innovations in nuclear
ardiology. The first contribution concerned optimization of
he use of radiopharmaceuticals labeled with 123I in nuclear
ardiology. 123I myocardial imaging is confounded by the
resence of multiple low-abundance high-energy photons
hich cause septal penetration in conventional collimators
sed for SPECT imaging, compromising both image qual-
ty and quantification of tracer activity. To help circumvent
his problem, Chen et al. (1) presented a novel mathematical
pproach that incorporates a three-dimensional deconvolu- tion of the septal penetration. In phantom studies the
uthors observed that optimal image quality and quantifi-
ation using 123iodium was obtained when deconvolution of
eptal penetration was added to processing of data acquired
ith schemes optimized for the energy window and scatter.
The second abstract concerned the assessment of LV
jection fraction from gated SPECT. Typically with MPI,
CG gating to assess LV function is performed post-stress
s opposed to peak-stress. Unfortunately, performing post-
tress imaging earlier results in marked degradation of
mage quality because of scattering artifacts induced from
xtra-cardiac activity. Hsu et al. (2) developed an approach
o facilitate the performance of early post-stress imaging
ith ECG gating. Their approach uses a novel energy-
ased scatter correction that separates photopeak from
cattered photons. The method was tested in 10 patients
nd normal volunteers undergoing same-day 99mTc-
estamibi rest/stress myocardial perfusion with ECG-gating
maging and attention correction. Although image quality
as slightly poorer and more susceptible to motion artifacts
n the images obtained early post-stress compared with
mages obtained at 30 to 60 min, there was reasonable
orrelation between the two image sets when comparing
egional activity in both normal and abnormal myocardium.
onsequently, image processing schemes that correct for
catter and are combined with accurate correction for
ttenuation and motion may facilitate the performance of
arly post-stress myocardial perfusion imaging using 99mTc
gents.
The third and fourth contributions were dedicated to
ttenuation correction with MPI. Attenuation-induced ar-
ifacts are the most common confounder of myocardial
erfusion imaging interpretation. Currently there are two
ethods to perform attenuation correction, using either
adioactive transmission sources or CT. In order for image
uantification and optimal diagnostic accuracy to be ob-
ained with these methods, normal databases that incorpo-
ate attenuation correction need to be generated. Esteves
t al. (3) demonstrated the feasibility of a normal database
omposed of adenosine stress 99mTc-sestamibi images with
ttenuation correction performed with 153Gd-transmission
ources. Dey et al. (4) evaluated the potential efficacy of
ttenuation correction on 99mTc-sestamibi MPI using a
PECT-CT (Symbia-6) imaging system in a group of
atients with variable levels of pre-test likelihood for coro-
ary artery disease. In over 90% of low likelihood patients,
ttenuation correction reduced myocardial perfusion defect
cores. Similarly, defect scores were also reduced by atten-
ation correction in both intermediate- and high-likelihood
atients, but to a lesser extent.
The fifth abstract concerned the additional prognostic
alue of MPI over exercise testing. The major strength of
PI is its ability to perform accurate risk stratification in
atients with known or suspected CAD and to provide
dded value to information derived from exercise treadmill
esting such as the Duke treadmill score. It is unknown
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April 4, 2006:1478–84 Meeting Highlights ASNC 2005hether MPI performs equally well in women where the
ikelihood of false positive exercise ECG findings is in-
reased. Lundbye et al. (5) addressed this question in 1,548
omen without known CAD in whom revascularization at
0 days was used as the primary end point. In women with
n intermediate-risk Duke treadmill score, the revascular-
zation rate was 0.8% in women with normal MPI, as
ompared with 25.6% in the presence of an abnormal MPI.
imilar results were observed in the high-risk Duke tread-
ill score group, where women with normal MPI had a
evascularization rate of 7.1%, as compared with 71.4% in
he presence of an abnormal MPI. Although further studies
re needed to determine if long-term prognosis differs
etween the groups, the data support the role of MPI as
rst-line evaluation of women in intermediate to high
re-test likelihood of CAD.
The sixth abstract concerned the prognostic value of
harmacologic stress MPI in conjunction with low-level
xercise. Athar et al. (6) addressed this issue in the study of
,814 patients referred for low-level exercise-dipyridamole
asodilator stress MPI with 99mTc-sestamibi. The authors
bserved that patients with (near) normal perfusion and a
ost-stress LV ejection fraction50% had a hard event rate
f 0.7%. Conversely, patients with abnormal perfusion and
V ejection fraction 50% had an event rate of 2.4%. The
esults of the study provide further evidence for the routine
ddition of low-level exercise to vasodilator stress myocar-
ial perfusion imaging.
The last abstract concerned better characterization of
atients with the MADIT II trial criteria. Paiesdana et al.
7) compared patients with the MADIT II trial criteria who
eceived or had not received an ICD. The authors evaluated
umerous variables including age, gender, LV ejection
raction, regional and global wall motion scores, and summed
tress and rest perfusion scores. The authors observed that
atients who received an ICD had worse global LV function
nd resting perfusion. Further studies are needed to determine
f these parameters can be used to identify patients who would
enefit from ICD placement.
ontemporary clinical contributions. Several abstracts
ocused on high-risk variables during stress MPI. Ventric-
lar ectopy during stress testing was reported to be associ-
ted with more extensive perfusion defects and lower
jection fraction (8). Mahajan et al. (9) demonstrated that
atients with isolated left main CAD had highly variable
cans, ranging from normal MPI to perfusion abnormalities
n multiple vascular territories. Another high-risk variable is
tress-induced LV dilation or transient ischemic dilation.
his was also associated with an impaired chronotropic
esponse to exercise (10). The cardiac event rate (death,
yocardial infarction, or unstable angina) was shown to be
ncreased during 18 months follow-up in patients with
ransient ischemic dilation (11).
The importance of recognizing non-cardiac findings on
ardiac SPECT scans was addressed by Raa et al. (12).
ncidental, non-cardiac findings were noted in 48 of 610 eatients (8%), the most common being abdominal abnor-
alities such as hepatosplenomegaly, gastrointestinal tu-
ors, and ascites, followed by breast, lung, and mediastinal
bnormalities, underscoring the need for the interpreting
hysician to carefully examine the acquired raw and tomo-
raphic images for these potentially significant findings.
ET. Investigations centered on cardiac PET included a
resentation by Bateman et al. (13) comparing 82Rb-PET
ith attenuation-corrected SPECT. The authors showed
hat the accuracy for detection of CAD was superior with
ET, because of better image quality with less bowel uptake
uring pharmacologic stress. An excellent short-term prog-
osis in patients with normal perfusion and function on
ated 82Rb-PET was also demonstrated (14).
The importance of transmission and emission scan reg-
stration with PET/CT was highlighted in a report from
ase et al. (15), observing that misregistration of greater
han 8 mm can introduce significant artifacts. Another
bstract evaluated quantitative myocardial blood flow on
ET in patients with and without diabetes. The authors
emonstrated that although resting flow was similar in diabet-
cs and non-diabetics, coronary flow reserve was decreased in
atients with diabetes. It was postulated that the presence of
mall vessel disease and/or endothelial dysfunction may be
ontributing to this blunted flow reserve, and PET may be
articularly useful to evaluate diabetic patients, because it
ermits absolute quantification of blood flow and flow
eserve.
pecial patient populations. Smanio et al. (16) reported
n the prognostic value of a normal SPECT scan in women
nd demonstrated that diabetic women had a substantially
igher cardiac event rate as compared with non-diabetic
omen over a four-year follow-up period. Another inter-
sting study observed that diabetics were more likely to have
PI abnormalities at a younger age than non-diabetics,
oting that diabetics in their fifth decade of life had an
ncidence of abnormal scans similar to a population of
ctogenarians without diabetes (17). One report focused on
he prognostic value of adenosine SPECT in patients with
nd-stage hepatic disease and demonstrated that a normal
can was associated with no cardiac events during short-
erm follow-up, suggesting that MPI can be used reliably for
isk stratification of this special population (18). A study of
atients screened for peripheral artery disease reported that
9% of those with an abnormal ankle-brachial index had
igh-risk SPECT findings (extensive perfusion abnormali-
ies, lower LV ejection fraction, and transient ischemic
ilation) (19).
ONCLUSIONS
wide range of topics in nuclear cardiology and other
on-invasive cardiac imaging techniques was presented
uring ASNC’s 10th Annual Scientific Sessions. Although
ore concepts were reviewed, this meeting featured cutting
dge research in cardiac imaging with radiopharmaceuticals,
w
i
m
i
R
m
d
l
R
1
1
1
1
1
1
1
1
1
1
1484 Bax et al. JACC Vol. 47, No. 7, 2006
Meeting Highlights ASNC 2005 April 4, 2006:1478–84ith an emphasis on unique clinical applications, the evolv-
ng integration between nuclear cardiology and CT, and
olecular imaging. Next year’s annual sessions will be held
n Montreal, Quebec, Canada on September 7 to 10, 2006.
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